drugset / Trial / NCT02875080
Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects
Non-randomizedCrossoverOpen-labelTreatment
Summary
The ratios of the geometric means of the ODT formulation to those of the reference formulation (conventional tablet) for the bioavailability variables (Cmax, AUCt, and AUC∞ of brexpiprazole (OPC-34712)).
Timeline
- Start
- 2016-09-27
- Primary completion
- 2016-11-27
- Completion
- 2016-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brexpiprazole | Small molecule | 4 mg | Oral |
Indications
No indication recorded.